Speaker(s): 

Vimal Bodiwala, MD, Staff Member, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  • 1) Describe the management of acute severe ulcerative colitis.
  • 2) Recognize the importance of pharmacologic prophylaxis against thromboembolism.
  • 3) Appreciate the importance of multidisciplinary care in taking care of hospitalized patients with IBD flares.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Stefanie Leader, DO, Stanley Martin, MD, Dan Dometita, DO, Malachi Courtney, MD, Eric Hossler, DO, Stacey Coolbaugh, RDN, and Donald Weider, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None

Session date: 
02/07/2025 - 12:00pm to 1:00pm EST
Location: 
Virtual via Microsoft Teams & Henry Hood Auditorium
Danville, PA 17822
United States
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 CDR
  • 1.00 Participation Credit

Please login or register to take this course.